Pharmacokinetics and Pharmacodynamics of Piperaquine in a Murine Malaria Model

B.R. Moore, K.T. Batty, C. Andrzejewski, J.D. Jago, M. Page-Sharp, Kenneth Ilett

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)


Piperaquine (PQ) is an important partner in antimalarial treatment strategies. However, there is a paucity of detailed preclinical and pharmacokinetic data to link PQ serum concentrations and toxicity or efficacy. The aim of this study was to investigate the pharmacokinetics and pharmacodynamics of PQ in a murine malaria treatment model. The study comprised three arms. (i) PQ pharmacokinetic parameters were determined in healthy and malaria-infected mice (90 mg/kg PQ phosphate [PQP]). (ii) For determination of single-dose pharmacodynamics, Swiss mice were inoculated with Plasmodium berghei parasites and given PQP (10, 30, or 90 mg/kg intraperitoneally) at 2 to 5% starting parasitemia. After 60 days, the 90-mg/kg PQP group was reinoculated with P. berghei. (iii) Combination efficacy was investigated at doses of 10 mg/kg PQP and 30 mg/kg dihydroartemisinin (DHA). The median survival times were 4, 10, and 54 days for 0, 10, and 30 mg/kg PQP, respectively. All mice given 90 mg/kg PQP survived beyond 60 days, with a mean parasitemia of
Original languageEnglish
Pages (from-to)306-311
JournalAntimicrobial Agents and Chemotherapy
Issue number1
Publication statusPublished - 2008


Dive into the research topics of 'Pharmacokinetics and Pharmacodynamics of Piperaquine in a Murine Malaria Model'. Together they form a unique fingerprint.

Cite this